Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the omisirge market grown in recent years?

The market size of omisirge has witnessed an XX (HCAGR) growth in the past few years. Forecasts predict a rise from $XX million in 2024 to $XX million in 2025, representing an annual compound growth rate (CAGR) of XX%. This growth during the historical period can be linked to the increased cases of chronic diseases, the surge in clinical trials, the growing elderly population, the improvement in healthcare infrastructure, and an upswing in research and development activities.

How is the omisirge market size expected to evolve during the forecast period?

The size of the omisirge market is projected to register an FCAGR of XX% in the upcoming years. By 2029, the market value is anticipated to reach $XX million through the compound annual growth rate (CAGR) of XX%. The growth during the forecasted period can be linked to heightened healthcare spending, increased government initiatives, a rise in disposable income, a surge in personalized medicine, and higher rates of cancer incidences. Key trends within this period will involve an emphasis on new product launches, tactical partnerships, technological advancements, drug authorizations from regulatory bodies, and investment in research and development activities.

Get your omisirge market report here!

https://www.thebusinessresearchcompany.com/report/omisirge-global-market-report

Which key drivers are propelling the omisirge market’s growth?

The omisirge market is expected to expand due to the increased incidence of cancer. Cancer, a range of diseases typified by uncontrolled growth and spread of abnormal cells, can invade nearby tissues and organs, possibly leading to fatal complications when unaddressed. Rising cancer rates can be credited to a combination of factors such as increased exposure to carcinogens like tobacco smoke, UV radiation, and several chemicals, an ageing population, changes in diet and lifestyle, and certain genetic alterations. Omisirge is an innovative treatment that aids cancer patients by targeting and adjusting the immune system to boost the body’s inherent cancer-fighting capabilities, providing a hopeful therapeutic route for some forms of cancer, particularly those that defy conventional therapies. As per the American Cancer Society, a non-profit cancer advocacy organization based in the US, the count of cancer cases surged to 1,958,310 in 2023, reflecting a 3.16% increase from 1,898,160 in 2021. Consequently, the escalating prevalence of cancer is fueling the growth of the omisirge market.

What are the market segments in the omisirge industry?

The omisirge market covered in this report is segmented –

1) By Clinical Indication: Leukemia; Lymphoma; Myeloma; Other Hematologic Malignancies

2) By Distribution Channel: Direct Sales; Distributors

3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20269&type=smp

Which leading companies are shaping the growth of the omisirge market?

Major companies operating in the omisirge market are Gamida Cell Ltd.

What key trends are currently impacting the omisirge market’s development?

A significant trend in the omisirge market entails acquiring drug approval from regulatory bodies in order to enhance competitiveness in the sector. This approval process involves a rigorous review and permission granted by regulatory bodies for a new drug’s sale, premised on its safety, effectiveness, and quality, as proven by clinical trials data. Take, for example, Gamida Cell Ltd., an American biotech firm that in April 2023 received approval from the U.S. Food and Drug Administration to sell Omisirge for both adult and pediatric patients aged 12 and above suffering from hematologic malignancies who have undergone umbilical cord blood transplantation following myeloablative conditioning. This milestone signifies a huge leap forward in cell therapy for patients with blood cancer since omisirge aids in speeding up neutrophil recovery and lessening infection risk. Omisirge, given as a single intravenous dose, comprises human allogeneic stem cells cultivated with nicotinamide, a variant of vitamin B3. Instead of utilizing the patient’s own cells, a healthy stem cell from an unrelated but meticulously chosen donor is used to create each patient’s dose.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20269

Which geographic areas are influencing the growth of the omisirge market?

North America was the largest region in the omisirge market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omisirge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Blood Cancer Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Global Autologous Cell Therapy Global Market Report 2025

https://thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Stem Cell Therapy Global Market Report 2025

https://thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: